K-State students to serve as speakers, musicians at fall 2023 graduations wibw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wibw.com Daily Mail and Mail on Sunday newspapers.
AbbVie is acquiring rival biotech firm ImmunoGen for $10.1 billion, giving it access to ImmunoGen's flagship ovarian cancer treatment Elahere, which was granted accelerated approval from the FDA last year.